Table 2 Gonadal hormones and radiological findings in the study groups
Study groups according to age | Total (n = 136) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
20–29 years (n = 49) | 30–39 years (n = 45) | 40–49 years (n = 42) | ||||||||||
MetS (n = 22) | Control (n = 27) | p value | MetS (n = 22) | Control (n = 23) | p value | MetS (n = 23) | Control (n = 19) | p value | MetS (n = 67) | Control (n = 69) | p value | |
Gonadal hormones | ||||||||||||
FSH (mIU/ml) | 7.5 ± 8.5 | 5.9 ± 1.4 | 0.31 | 6.2 ± 2.4 | 6.3 ± 2.3 | 0.87 | 7.9 ± 3.4 | 8.0 ± 3.5 | 0.95 | 7.3 ± 5.4 | 6.6 ± 2.6 | 0.381 |
LH (mIU/ml) | 5.7 ± 2.9 | 5.5 ± 2.1 | 0.77 | 5.6 ± 2.7 | 5.3 ± 2.4 | 0.72 | 6.3 ± 3.5 | 5.6 ± 2.3 | 0.46 | 5.92 ± 3.1 | 5.5 ± 2.2 | 0.380 |
FSH/LH | 1.5 ± 1.7 | 1.2 ± 0.5 | 0.4 | 1.3 ± 0.6 | 1.4 ± 0.8 | 0.69 | 1.4 ± 0.5 | 1.5 ± 0.6 | 0.65 | 1.41 ± 1.1 | 1.34 ± 0.7 | 0.593 |
E2 (pg/ml) | 35.8 ± 16.4 | 36.1 ± 14.9 | 0.94 | 35.3 ± 17.0 | 38.3 ± 15.0 | 0.53 | 41.4 ± 18.6 | 39.4 ± 13.1 | 0.7 | 37.6 ± 17.4 | 37.8 ± 14.4 | 0.940 |
Progesteron (ng/ml) | 0.4 ± 0.2 | 0.8 ± 1.6 | 0.37 | 0.5 ± 0.8 | 0.6 ± 0.8 | 0.73 | 0.5 ± 0.8 | 0.4 ± 0.4 | 0.5 | 0.5 ± 0.7 | 0.6 ± 1.1 | 0.495 |
Testosteron (ng/ml) | 0.3 ± 0.1 | 0.2 ± 0.1 | 0.018 | 0.2 ± 0.1 | 0.2 ± 0.1 | 0.17 | 0.2 ± 0.1 | 0.2 ± 0.1 | 0.57 | 0.2 ± 0.1 | 0.2 ± 0.1 | 0.024 |
Radiological findings | ||||||||||||
Total ovarian volume (cm3) | 7.5 ± 2.8 | 9.3 ± 2.3 | 0.018 | 7.0 ± 2.0 | 8.5 ± 3.2 | 0.07 | 5.9 ± 2.2 | 6.1 ± 1.4 | 0.77 | 6.8 ± 2.4 | 8.2 ± 2.8 | 0.003 |
Total antral follicle count | 24.7 ± 17.9 | 28.5 ± 11.9 | 0.37 | 24.1 ± 21.6 | 23.4 ± 14.1 | 0.89 | 12.7 ± 13.0 | 8.1 ± 5.5 | 0.152 | 20.4 ± 18.4 | 21.2 ± 14.1 | 0.77 |